AAA reports over 24% growth in sales for the first quarter of 2015
Advanced Accelerator Applications S.A. announced on 15 June 2015 its financial results for the first quarter of 2015.
The company receives FDA Fast Track Designation for Lutathera for the treatment of midgut neuroendocrine tumors.
For more information, download the press release >>
- Bando INNOWWIDE per VAP – Viability Assessment Projects
- BROKERAGE EVENT S3martMed needs SmartTech – Serving tomorrow’s medical devices
- Posticipata la chiusura della Call for Startup del programma di accelerazione BioUpper
- Webinar S3MARTMED Horizon2020 calls – How to fund your transnational cooperation project
- Evolutio Startup, l’accelleratore per l’innovazione nel settore Salute